ClinicalTrials.Veeva

Menu

Ultrasound-guided Regional Anesthesia vs Local Infiltration Anesthesia With Dexmedetomidine and Ropivacaine

M

Medical University of Graz

Status and phase

Completed
Phase 3

Conditions

Anesthesia, Local
Pain, Postoperative
Gonarthrosis

Treatments

Drug: Local infiltration analgesia
Drug: Ultrasound guided regional anesthesia

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Evaluation of the Impact of dexmedetomidine as an adjunct for local infiltrations analgesia and ultrasound-based regional anaesthesia as pain medication in regard to patients' opioid need the first 48 hours after the total knee replacement operation.

Full description

Evaluation of the Impact of dexmedetomidine as an adjunct for local infiltrations analgesia and ultrasound-based regional anaesthesia as pain medication in regard to patients' opioid need the first 48 hours after the total knee replacement operation. Secondary objectives are: Pain assesment, Pain medication necessary, functionality of the prothesis, satisfaction, wellbeing, postoperative discomforts, complications (delirium, allergic reactions, cardiopulmonary decompensation), procedure specific time.

Enrollment

50 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult
  • non pregnant
  • patients with gonarthrosis who have given written consent for participation

Exclusion criteria

  • Age below 18 years
  • pregnancy
  • breast-feeding patients
  • allergies against study medication
  • missing or denied written consent

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

50 participants in 2 patient groups

Ultrasound guided regional anesthesia
Active Comparator group
Description:
Patient will be given a peripheral nerve block from their treating anesthesiologist before the operation (in the OR) with an conventional ultrasound guided femoral and sciatic block of each 15 ml ropivacaine 0,5% and 0,5 ml dexmedetomidine (100µg/ml).
Treatment:
Drug: Ultrasound guided regional anesthesia
Local infiltration analgesia
Active Comparator group
Description:
Patient will be given a local infiltration analgesia from their treating surgeon during the operation (in the OR) with 60 ml ropivacaine 0,5% and 1 ml dexmedetomidine (100µg/ml).
Treatment:
Drug: Local infiltration analgesia

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems